The Journal of Hip Surgery 2020; 04(02): 060-065
DOI: 10.1055/s-0040-1712519
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Tall-Statured Patients Have Similar Outcomes to Normal Height Patients after Primary Total Hip Arthroplasty

Ahmed Siddiqi*
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Jared A. Warren
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Michael Groover
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Daniel Santana
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Hiba K. Anis
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Atul F. Kamath
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Robert M. Molloy
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
,
Carlos A. Higuera
2   Department of Orthopedic Surgery, Cleveland Clinic Florida, Weston, Florida
,
Nicolas S. Piuzzi
1   Department of Orthopedic Surgery, Cleveland Clinic, Cleveland, Ohio
› Author Affiliations
Funding None
Further Information

Publication History

24 December 2019

16 March 2020

Publication Date:
30 June 2020 (online)

Abstract

Total hip arthroplasty (THA) has been proven to be a safe and efficacious operation; however, there is a paucity of literature on outcomes in patients in the 99th percentile for height. The objectives of this study were to identify differences in (1) implant selection, (2) operative times, (3) intraoperative and postoperative complications, (4) 90-day readmission, (5) all cause reoperation rates, and (6) hospital length of stay (LOS), in tall-statured patients compared with a matched control cohort. An electronic research request was used to identify 12,850 patients who underwent THA from January 2012 to December 2016 with minimum 1-year follow-up at a single health care system for retrospective chart review. Patients were identified in the 99th percentile for height (193 cm for males and 177 cm for females) and then matched to controls based on gender, race, age, body mass index, and Charlson comorbidity index. A total of 260 THA patients (2%) were identified in the 99th percentile for height. The tall-statured patients were then matched to 248 patients of normal stature. The exclusion criteria was met by 172 tall-statured patients and 165 normal-statured patients. Final analysis comprised of 86 tall-statured patients (100 THA) and 83 matched normal-statured patients (92 THA). Baseline demographics information and the outcomes of interest were then compared. The mean height of the female patients in the tall cohort was 181.01 ± 2.51 cm compared with 166.6 ± 6.98 cm for the control group (p < 0.001), while it was 195.25 ± 4.03 cm for male patients in the tall cohort and 174.11 ± 4.63 cm for the control cohort (p < 0.001). Tall-statured patients had larger acetabular cups (p < 0.001) and femoral head (p = 0.046) components. There were no differences in reoperation (p = 0.282), 90-day readmissions (p = 0.862), intraoperative fractures (p = 0.228), postoperative complications (p = 0.678), operative times (p = 0.890), and LOS (p = 0.099) between the tall-statured and normal-statured patients. Patients that are in the 99th percentile for height have similar outcomes to patients that are of normal height. The level of evidence of this study is level 3.

* Co-First Authors.


 
  • References

  • 1 Kremers HM, Larson DR, Crowson CS. , et al. Prevalence of total hip and knee replacement in the United States. J Bone Joint Surg Am 2015; 97 (17) 1386-1397
  • 2 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 3 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
  • 4 Issa K, Harwin SF, Malkani AL, Bonutti PM, Scillia A, Mont MA. Bariatric orthopaedics: total hip arthroplasty in super-obese patients (those with a BMI of ≥50.  kg/m2). J Bone Joint Surg Am 2016; 98 (03) 180-185
  • 5 Rawal B, Ribeiro R, Malhotra R, Bhatnagar N. Anthropometric measurements to design best-fit femoral stem for the Indian population. Indian J Orthop 2012; 46 (01) 46-53
  • 6 Husmann O, Rubin PJ, Leyvraz PF, de Roguin B, Argenson JN. Three-dimensional morphology of the proximal femur. J Arthroplasty 1997; 12 (04) 444-450
  • 7 Noble PC, Alexander JW, Lindahl LJ, Yew DT, Granberry WM, Tullos HS. The anatomic basis of femoral component design. Clin Orthop Relat Res 1988; (235) 148-165
  • 8 De Fine M, Traina F, Palmonari M, Tassinari E, Toni A. Total hip arthroplasty in dwarfism. A case report. Chir Organi Mov 2008; 92 (01) 67-69
  • 9 Huo MH, Salvati EA, Lieberman JR, Burstein AH, Wilson PD. Custom-designed femoral prostheses in total hip arthroplasty done with cement for severe dysplasia of the hip. J Bone Joint Surg Am 1993; 75 (10) 1497-1504
  • 10 Rittmeister M, Bischof F, Starker M. Individual cement-free total hip endoprosthesis in a patient with a rare form of dwarfism (Fuhrmann syndrome) [in German]. Z Orthop Ihre Grenzgeb 2000; 138 (03) 235-239
  • 11 Wirtz DC, Birnbaum K, Siebert CH, Heller KD. Bilateral total hip replacement in pseudoachondroplasia. Acta Orthop Belg 2000; 66 (04) 405-408
  • 12 Di Fazio F, Shon WY, Salvati EA, Wilson PD. Long-term results of total hip arthroplasty with a cemented custom-designed swan-neck femoral component for congenital dislocation or severe dysplasia: a follow-up note. J Bone Joint Surg Am 2002; 84 (02) 204-207
  • 13 Chiavetta JB, Parvizi J, Shaughnessy WJ, Cabanela ME. Total hip arthroplasty in patients with dwarfism. J Bone Joint Surg Am 2004; 86 (02) 298-304
  • 14 Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40 (05) 373-383
  • 15 U.S. National Center for Health Statsitcs. Table 205. Cumulative Percent Distribution of Population by Height and Sex: 2007 to 2008. Hyattsville, MD: U.S. Census Bureau, Statistical Abstract of the United States; 2011
  • 16 Haynes J, Nam D, Barrack RL. Obesity in total hip arthroplasty: does it make a difference?. Bone Joint J 2017; 99-B (1, suppl A): 31-36
  • 17 Dowsey MM, Choong PFM. Obesity is a major risk factor for prosthetic infection after primary hip arthroplasty. Clin Orthop Relat Res 2008; 466 (01) 153-158
  • 18 Choong PFM, Dowsey MM, Liew D. Obesity in total hip replacement. J Bone Joint Surg Br 2009; 91 (12) 1642
  • 19 Ortega FB, Sui X, Lavie CJ, Blair SN. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality?. Mayo Clin Proc 2016; 91 (04) 443-455
  • 20 Fryar CD, Kruszon-Moran D, Gu Q, Ogden CL. Mean body weight, height, waist circumference, and body mass index among adults: United States, 1999-2000 through 2015-2016. Natl Health Stat Rep 2018; (122) 1-16
  • 21 Kumar S. Tall stature in children: differential diagnosis and management. Int J Pediatr Endocrinol 2013; 2013 (Suppl. 01) P53
  • 22 Karns MR, Patel SH, Kolaczko J. , et al. Acetabular rim length: an anatomical study to determine reasonable graft sizes for labral reconstruction. J Hip Preserv Surg 2016; 4 (01) 106-112
  • 23 Peter R, Lübbeke A, Stern R, Hoffmeyer P. Cup size and risk of dislocation after primary total hip arthroplasty. J Arthroplasty 2011; 26 (08) 1305-1309
  • 24 Saragaglia D, Belvisi B, Rubens-Duval B, Pailhé R, Rouchy RC, Mader R. Clinical and radiological outcomes with the Durom™ acetabular cup for large-diameter total hip arthroplasty: 177 implants after a mean of 80 months. Orthop Traumatol Surg Res 2015; 101 (04) 437-441
  • 25 Naal FD, Kain MSH, Hersche O, Munzinger U, Leunig M. Does hip resurfacing require larger acetabular cups than conventional THA?. Clin Orthop Relat Res 2009; 467 (04) 923-928
  • 26 Schmidutz F, Fottner A, Wanke-Jellinek L, Steinbrück A, Jansson V, Mazzochian F. Hip resurfacing requires larger acetabular cups than conventional hip replacement: a comparative analysis of 100 hips, based on radiographic templating. Acta Orthop Belg 2012; 78 (04) 484-491
  • 27 Cho M-R, Choi WK, Kim JJ. Current concepts of using large femoral heads in total hip arthroplasty. Hip Pelvis 2016; 28 (03) 134-141
  • 28 Cooper HJ, Della Valle CJ. Large diameter femoral heads: is bigger always better?. Bone Joint J 2014; 96B ( 11 suppl. A): 23-26
  • 29 Rodriguez JA, Cooper HJ. Large ceramic femoral heads: what problems do they solve?. Bone Joint J 2013; 95-B (11, suppl A ): 63-66
  • 30 Koo KH, Ha YC, Kim SY, Yoon KS, Min BW, Kim SR. Revision of ceramic head fracture after third generation ceramic-on-ceramic total hip arthroplasty. J Arthroplasty 2014; 29 (01) 214-218
  • 31 Tai SMM, Parker L, de Roeck NJ, Skinner JA. Recurrent catastrophic ceramic femoral head failure in total hip arthroplasty. Case Rep Orthop 2014; 2014: 837954
  • 32 Wurtz LD, Feinberg JR, Capello WN, Meldrum R, Kay PJ. Elective primary total hip arthroplasty in octogenarians. J Gerontol A Biol Sci Med Sci 2003; 58 (05) M468-M471
  • 33 Stihsen C, Springer B, Nemecek E. , et al. Cementless total hip arthroplasty in octogenarians. J Arthroplasty 2017; 32 (06) 1923-1929